Cargando…
Biased Multicomponent Reactions to Develop Novel Bromodomain Inhibitors
[Image: see text] BET bromodomain inhibition has contributed new insights into gene regulation and emerged as a promising therapeutic strategy in cancer. Structural analogy of early methyl-triazolo BET inhibitors has prompted a need for structurally dissimilar ligands as probes of bromodomain functi...
Autores principales: | McKeown, Michael R, Shaw, Daniel L, Fu, Harry, Liu, Shuai, Xu, Xiang, Marineau, Jason J, Huang, Yibo, Zhang, Xiaofeng, Buckley, Dennis L, Kadam, Asha, Zhang, Zijuan, Blacklow, Stephen C, Qi, Jun, Zhang, Wei, Bradner, James E |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Chemical
Society
2014
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4234447/ https://www.ncbi.nlm.nih.gov/pubmed/25314271 http://dx.doi.org/10.1021/jm501120z |
Ejemplares similares
-
Selective inhibition of BET bromodomains
por: Filippakopoulos, Panagis, et al.
Publicado: (2010) -
Bias in Auditory Perception
por: Sloos, Marjoleine, et al.
Publicado: (2015) -
Multicomponent reactions
por: Müller, Thomas J J
Publicado: (2011) -
Multicomponent Reactions
por: Cimarelli, Cristina
Publicado: (2019) -
Functional TRIM24 degrader via conjugation of ineffectual bromodomain and VHL ligands
por: Gechijian, Lara N., et al.
Publicado: (2018)